Category Archives: Irritable Bowel Syndrome

IBS Impact’s Top 20 (or 38!) Countries and Top 20 Posts of 2020

For the New Year, IBS Impact is once again participating in the common December-January blogger tradition of highlighting popular posts and interesting blog statistics from the year just past. This blog reached readers in 79 countries and territories during 2020. The cumulative total is 167 for the nine years WordPress has made country statistics available …

Continue reading

American College of Gastroenterology Publishes 2020 Guidelines for Management of Irritable Bowel Syndrome (IBS), December 2020

The American Journal of Gastroenterology has published the American College of Gastroenterology’s  newly updated guidelines for the management of irritable bowel syndrome (IBS) in its December 2020 issue. Seven named authors from the fields of gastroenterology  and gastrointestinal health psychology, represent five United States universities or academic medical centers that are leaders in IBS research. …

Continue reading

Online Study: Transition Experiences of Patients with Functional GI Disorders

The following research study is being conducted through a collaboration of Baylor College of Medicine, Texas Children’s Hospital, the University of Miami and the International Foundation for Gastrointestinal Disorders. Please address any questions directly to Dr. Shapiro at the email address below. “The transition from pediatric to adult care can be challenging for a number …

Continue reading

Updates to IBS Impact.com Main Website, October 2020

IBS Impact has recently completed the latest round of updates to many pages of our main website,  IBS Impact.com, The advocacy page, research page, IBS studies page, resources page, family and friends page,ibs and children page, and links page, plus the news updates in the blue and white footers of every page all have additions …

Continue reading

Reps. Butterfield of North Carolina and McGovern of Massachusetts Co-Sponsor Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396)

According to IFFGD and the official Congressional legislative database Congress.gov, earlier this month,Representative G.K. Butterfield (D-NC-1) and Representative James McGovern (D-MA-2)  officially became co-sponsors for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. Each of them is co-sponsoring for the first time. IBS Impact thanks them for taking the time …

Continue reading

Online Research Survey on Psychological Health of People with IBS During the COVID-19 Emergency, University of Chieti, May 2020

Posted at the request of one of the researchers involved in the Department of Psychological Health and Territorial Sciences, University of Chieti, Pescara, Italy. This is an anonymous online survey on “factors affecting health outcomes in people with IBS during the COVID-19 emergency.” The research team is seeking adults aged 18-74 with a physician diagnosis …

Continue reading

A Dozen Years and 13 IBS Awareness Months: Advances for the IBS Community 2019-2020

by Nina Pan, IBS Impact founder and primary blogger for IBS Impact. Seven years ago, on April 24, 2013, I wrote a post for IBS Awareness Month that began with some reflections on my personal experiences with IBS, as well as my motivations for IBS Impact. At that time, I had been living with IBS for …

Continue reading

Guest Post for IBS Awareness Month: Living With IBS

IBS Impact is pleased to welcome a guest post for IBS Awareness Month. Feivel Cohen has IBS and intellectual disabilities and lives and works in Maryland (USA). He wrote this article himself especially for IBS Impact. To respect his real voice as a self-advocate, we have intentionally not edited his own choice of words and …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2020

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of diabetes, chronic …

Continue reading

Reps. Brownley of California, Suozzi of New York and Norton of the District of Columbia Co-Sponsor Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396)

According to IFFGD and the official Congressional legislative database Congress.gov, last week, Representative Julia Brownley (D-CA-26), Representative Thomas Suozzi (D-NY-3) and Representative Eleanor Holmes Norton (D-DC-at large)  officially became co-sponsors for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. Each of them was a co-sponsor of a previous version of …

Continue reading